Stavick 30 Capsule contains Stavudine 30mg, a nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment and management of HIV infection. It helps in reducing viral load and improving immune system function in patients living with HIV.
Stavudine works by blocking the reverse transcriptase enzyme, preventing viral replication and supporting sustained suppression of HIV. This mechanism helps in slowing disease progression and improving patient health outcomes.
This capsule is widely prescribed as part of combination antiretroviral therapy (ART), ensuring effective viral control and supporting long-term HIV management. Its oral dosage offers convenience and better adherence in chronic therapy regimens.
For PCD pharma franchise partners, Stavick 30 Capsule is a high-demand antiretroviral product, available at best price for PCD pharma franchise, making it ideal for hospitals, clinics, pharmacies, and export markets. Its clinical trust and consistent demand make it a valuable addition to any HIV care portfolio.
Common side effects may include headache, nausea, diarrhea, fatigue, or mild abdominal discomfort. Rare but serious side effects include peripheral neuropathy, lactic acidosis, pancreatitis, liver toxicity, or severe allergic reactions. Immediate medical attention should be sought if severe symptoms occur.
Stavick 30 Capsule is indicated for the treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy, as prescribed by a healthcare professional.
Stavick 30 Capsule should be taken exactly as prescribed, usually in combination with other antiretroviral medications. Regular monitoring of liver function, blood counts, and viral load is recommended. Inform the doctor of any history of liver or kidney disease, peripheral neuropathy, or other medications being taken.
Store Stavick 30 Capsule in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use beyond the expiry date printed on the packaging.